Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

26.3K
Overview
26.3K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

277
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
277
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma I: Introduction01:28

Asthma I: Introduction

88
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
88
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

38
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
38
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term efficacy and safety of dupilumab in patients enrolled from Latin American centers from the open-label extension LIBERTY ASTHMA TRAVERSE study.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization Level.

The journal of allergy and clinical immunology. In practice·2026
Same author

Coexisting Type 2 Inflammatory Conditions in Patients with Asthma Treated with Dupilumab: the RAPID Registry.

Advances in therapy·2026
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy·2026
Same author

Treatment burden and healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: a US real-world retrospective cohort study.

Journal of comparative effectiveness research·2026
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Allergy·2025

Related Experiment Video

Updated: Apr 27, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.9K

Current Allergic Rhinitis Experiences Survey (CARES): Consumers' awareness, attitudes and practices.

Leonard M Fromer1, Michael S Blaiss, Juby A Jacob-Nara

  • 1University of California, Los Angeles, School of Medicine, Los Angeles, California, USA.

Allergy and Asthma Proceedings
|July 4, 2014
PubMed
Summary

Most allergic rhinitis (AR) sufferers believe they can self-diagnose and manage symptoms with over-the-counter (OTC) options. However, many desire more effective OTC treatments for better allergic rhinitis control.

More Related Videos

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.7K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.8K

Related Experiment Videos

Last Updated: Apr 27, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.9K
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.7K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.8K

Area of Science:

  • Allergy and Immunology
  • Public Health
  • Pharmacology

Background:

  • Allergic rhinitis (AR) is a prevalent condition affecting millions in the U.S.
  • Patient self-management is a key aspect of AR care.
  • Understanding patient perceptions is crucial for optimizing AR management strategies.

Purpose of the Study:

  • To evaluate awareness, attitudes, and behaviors of U.S. adults with AR regarding condition management.
  • To assess perceptions of AR diagnosis, treatment preferences, and healthcare practitioner (HCP) interactions.
  • To compare experiences between users of over-the-counter (OTC) medications and prescription (Rx) medications.

Main Methods:

  • A U.S.-based survey of 1600 adult AR sufferers.
  • Categorization into two groups: OTC-only users (n=1020) and Rx ± OTC users (n=580), including 451 intranasal steroid (INS) users.
  • Assessment of self-recognition of symptoms, diagnosis, treatment choices, and HCP engagement.

Main Results:

  • 82% felt minimal HCP guidance was needed for AR management; 51% hadn't seen an HCP in 2 years.
  • 86% believed they could self-recognize AR symptoms; 52% used OTCs upon suspicion.
  • 72% would consult an HCP if OTCs failed; Rx users favored INSs (satisfaction 7.4/10).

Conclusions:

  • AR sufferers often self-diagnose and initiate treatment with OTC medications.
  • The availability of OTCs does not prevent seeking professional help for persistent symptoms.
  • A significant unmet need exists for more effective OTC options for AR symptom management.